# Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler
> **Rule** · Interim final rule. · Published 2015-10-27 · 80 FR 65632
## Document
- **Document number:** 2015-27264
- **Category:** other
- **Type:** Rule
- **Action:** Interim final rule.
- **Citation:** 80 FR 65632
- **Publication date:** 2015-10-27
## Abstract

The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 milligrams levmetamfetamine) to Aphena Pharma Solutions--New York, LLC. This over-the-counter, nonnarcotic drug product is excluded from the provisions of the Controlled Substances Act.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2015/10/27/2015-27264/schedules-of-controlled-substances-table-of-excluded-nonnarcotic-products-nasal-decongestant)
---
*AI Analytics · CC0 1.0*